LOGIN  |  REGISTER
Astria Therapeutics
Viking Therapeutics

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

July 19, 2023 | Last Trade: US$3.14 0.00 0.00

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
06/30/202396,250,954 

Total gross of voting rights: 96,250,954

 
 

Total net* of voting rights: 96,100,982

 

* Net total = total number of voting rights attached to shares – shares without voting rights = 96,250,954 –149,972= 96,100,982

C4 Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB